Metformin as a Therapeutic Target in Endometrial Cancers

Endometrial cancer is the most common gynecologic malignancy in developed countries. Its increasing incidence is thought to be related in part to the rise of metabolic syndrome, which has been shown to be a risk factor for the development of hyperestrogenic and hyperinsulinemic states. This has cons...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Teresa Y., Martinez-Outschoorn, Ubaldo E., Schilder, Russell J., Kim, Christine H., Richard, Scott D., Rosenblum, Norman G., Johnson, Jennifer M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121131/
https://www.ncbi.nlm.nih.gov/pubmed/30211120
http://dx.doi.org/10.3389/fonc.2018.00341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121131/
https://www.ncbi.nlm.nih.gov/pubmed/30211120
http://dx.doi.org/10.3389/fonc.2018.00341

Ejemplares similares